GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » Cyclically Adjusted Price-to-FCF

Tandem Diabetes Care (FRA:TD5A) Cyclically Adjusted Price-to-FCF : (As of Apr. 30, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Chart

Tandem Diabetes Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tandem Diabetes Care Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF falls into.



Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Tandem Diabetes Care's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Tandem Diabetes Care's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.487/129.4194*129.4194
=-0.487

Current CPI (Dec. 2023) = 129.4194.

Tandem Diabetes Care Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -5.910 99.695 -7.672
201406 -5.853 100.560 -7.533
201409 -4.811 100.428 -6.200
201412 -4.913 99.070 -6.418
201503 -5.828 99.621 -7.571
201506 -6.111 100.684 -7.855
201509 -4.770 100.392 -6.149
201512 -3.626 99.792 -4.703
201603 -5.304 100.470 -6.832
201606 -4.552 101.688 -5.793
201609 -5.903 101.861 -7.500
201612 -5.013 101.863 -6.369
201703 -6.877 102.862 -8.653
201706 -2.860 103.349 -3.581
201709 -3.114 104.136 -3.870
201712 -1.091 104.011 -1.358
201803 -0.576 105.290 -0.708
201806 -0.123 106.317 -0.150
201809 -0.069 106.507 -0.084
201812 0.202 105.998 0.247
201903 -0.085 107.251 -0.103
201906 -0.049 108.070 -0.059
201909 0.282 108.329 0.337
201912 0.193 108.420 0.230
202003 -0.415 108.902 -0.493
202006 0.013 108.767 0.015
202009 0.107 109.815 0.126
202012 0.147 109.897 0.173
202103 0.338 111.754 0.391
202106 0.224 114.631 0.253
202109 0.407 115.734 0.455
202112 0.190 117.630 0.209
202203 0.159 121.301 0.170
202206 -0.085 125.017 -0.088
202209 0.030 125.227 0.031
202212 0.003 125.222 0.003
202303 -0.393 127.348 -0.399
202306 -0.231 128.729 -0.232
202309 -0.077 129.860 -0.077
202312 -0.487 129.419 -0.487

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tandem Diabetes Care  (FRA:TD5A) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tandem Diabetes Care (FRA:TD5A) Business Description

Traded in Other Exchanges
Address
11075 Roselle Street, San Diego, CA, USA, 92121
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care (FRA:TD5A) Headlines

No Headlines